Danimer Scientific, Inc. (DNMR)
NYSE: DNMR · Real-Time Price · USD
8.64
-0.17 (-1.93%)
Nov 15, 2024, 4:00 PM EST - Market closed
Danimer Scientific Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 39.75 | 46.68 | 53.22 | 58.75 | 47.33 | 32.34 | Upgrade
|
| Revenue Growth (YoY) | -21.40% | -12.28% | -9.41% | 24.12% | 46.34% | 6.21% | Upgrade
|
| Cost of Revenue | 64.17 | 71 | 61.13 | 55.95 | 34.47 | 20.88 | Upgrade
|
| Gross Profit | -24.43 | -24.32 | -7.91 | 2.8 | 12.86 | 11.47 | Upgrade
|
| Selling, General & Admin | 51.16 | 72.54 | 84.63 | 82.19 | 16.98 | 16.83 | Upgrade
|
| Research & Development | 23.71 | 28.33 | 31.4 | 20 | 7.32 | 5.04 | Upgrade
|
| Operating Expenses | 74.87 | 100.87 | 116.03 | 102.19 | 24.3 | 21.87 | Upgrade
|
| Operating Income | -99.29 | -125.19 | -123.94 | -99.39 | -11.44 | -10.4 | Upgrade
|
| Interest Expense | -35 | -29.64 | -1.72 | -0.76 | -2.08 | -3.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.08 | 0.21 | 10.09 | 27.72 | 3.69 | 0.28 | Upgrade
|
| EBT Excluding Unusual Items | -128.21 | -154.62 | -115.58 | -72.43 | -9.83 | -13.26 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -4.3 | - | Upgrade
|
| Impairment of Goodwill | - | - | -62.7 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.64 | -0.25 | -0 | -0.08 | 0.01 | 0.28 | Upgrade
|
| Asset Writedown | -0.19 | -0.19 | -0.79 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | - | -8 | Upgrade
|
| Other Unusual Items | - | -0.1 | -1.5 | -0.83 | 5.27 | 5.55 | Upgrade
|
| Pretax Income | -129.04 | -155.15 | -180.57 | -73.34 | -8.85 | -15.43 | Upgrade
|
| Income Tax Expense | 0.47 | 0.32 | -0.81 | -13.23 | - | 4.09 | Upgrade
|
| Net Income | -129.52 | -155.47 | -179.76 | -60.11 | -8.85 | -19.51 | Upgrade
|
| Net Income to Common | -129.52 | -155.47 | -179.76 | -60.11 | -8.85 | -19.51 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 3 | 2 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 2 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 4.42% | 0.90% | 8.61% | 214.76% | 16.72% | 756.21% | Upgrade
|
| EPS (Basic) | -48.83 | -60.97 | -71.12 | -25.83 | -11.98 | -30.81 | Upgrade
|
| EPS (Diluted) | -48.83 | -60.97 | -71.12 | -25.83 | -11.98 | -30.81 | Upgrade
|
| Free Cash Flow | -66.49 | -74.95 | -226.32 | -248.37 | -52.07 | -38.23 | Upgrade
|
| Free Cash Flow Per Share | -25.07 | -29.39 | -89.55 | -106.74 | -70.43 | -60.36 | Upgrade
|
| Gross Margin | -61.46% | -52.09% | -14.86% | 4.77% | 27.17% | 35.45% | Upgrade
|
| Operating Margin | -249.83% | -268.15% | -232.89% | -169.18% | -24.16% | -32.16% | Upgrade
|
| Profit Margin | -325.87% | -333.03% | -337.78% | -102.31% | -18.70% | -60.33% | Upgrade
|
| Free Cash Flow Margin | -167.29% | -160.55% | -425.28% | -422.77% | -110.00% | -118.21% | Upgrade
|
| EBITDA | -69.7 | -95.81 | -103.49 | -87.72 | -6.83 | -6.9 | Upgrade
|
| EBITDA Margin | -175.37% | -205.23% | -194.46% | -149.31% | -14.43% | -21.32% | Upgrade
|
| D&A For EBITDA | 29.59 | 29.38 | 20.45 | 11.67 | 4.61 | 3.51 | Upgrade
|
| EBIT | -99.29 | -125.19 | -123.94 | -99.39 | -11.44 | -10.4 | Upgrade
|
| EBIT Margin | -249.83% | -268.15% | -232.89% | -169.18% | -24.16% | -32.16% | Upgrade
|
| Revenue as Reported | 39.75 | 46.68 | 53.22 | 58.75 | 47.33 | 32.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.